Moleculin Biotech, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.3M | $10.3M | $8.9M | $6.7M | $7.6M | $7.7M | $4.3M | $9.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $8.7M | $11.0M | $9.7M | $7.9M | $9.1M | $9.3M | $5.2M | $11.6M |
| Property, Plant & Equipment | $62.0K | $70.0K | $78.0K | $77.0K | $99.0K | $127.0K | $159.0K | $190.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $21.1M | $23.4M | $22.1M | $20.4M | $21.6M | $21.0M | $16.9M | $23.4M |
| Liabilities | ||||||||
| Accounts Payable | $4.3M | $4.6M | $3.5M | $2.1M | $3.7M | $2.7M | $2.0M | $2.6M |
| Total Current Liabilities | $9.3M | $8.0M | $6.9M | $5.7M | $7.9M | $6.9M | $5.4M | $5.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $9.5M | $8.2M | $7.1M | $47.3M | $25.2M | $7.2M | $5.7M | $15.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-226.5M | $-218.8M | $-206.0M | $-221.6M | $-196.2M | $-178.3M | $-172.4M | $-151.5M |
| Total Stockholders' Equity | $11.6M | $15.2M | $15.0M | $-26.9M | $-3.6K | $13.8M | $11.2M | $17.4M |